Elraglusib

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Elraglusib
Treatment and conditionWhere it standsTrials
Elraglusib for gliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elraglusib for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elraglusib for neoplasm metastasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elraglusib for sarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1